Robert L. Van Nostrand - Insider Trading & Ownership

Entity
Individual
Location
C/O Achillion Pharmaceuticals, Inc., 300 George Street, New Haven, CT
Summary
The estimated net worth of Robert L. Van Nostrand is at least $856K dollars as of July 2, 2024. Robert L. Van Nostrand is the Director of Intra-Cellular Therapies, Inc. and owns shares of Intra-Cellular Therapies, Inc. (ITCI) stock worth about $777K. Robert L. Van Nostrand is the Director of SELLAS Life Sciences Group, Inc. and owns shares of SELLAS Life Sciences Group, Inc. (SLS) stock worth about $65K. Robert L. Van Nostrand is the Director of YIELD10 BIOSCIENCE, INC. and owns shares of YIELD10 BIOSCIENCE, INC. (YTEN) stock worth about $14.6K.
All Insider Reports
All Insider Reports

Ownership of Robert L. Van Nostrand

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ITCI Intra-Cellular Therapies, Inc. Director $777K -$2.98M -79.3% Jun 28, 2024
SLS SELLAS Life Sciences Group, Inc. Director $65K Jan 22, 2024
YTEN YIELD10 BIOSCIENCE, INC. Director $14.6K Mar 28, 2024

Insider Transactions Reported by Robert L. Van Nostrand:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.